Tag Archives: The Stem Cell Blog

The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be … – EurekAlert (press release)

Continue reading

2017-06-03 NEWS

Medical Daily

The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be …
EurekAlert (press release)
The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to an international clinical trial led by NYU Langone’s Perlmutter …
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily

all 2 news articles »

Continue reading

2017-06-03 NEWS

Medical Daily

Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer
PR Newswire (press release)
NEW YORK, June 3, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug pembrolizumab—already FDA-approved for other forms of cancer–has been found to be effective in patients with metastatic triple negative breast cancer, according to an …
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily

all 2 news articles »

Continue reading

2017-06-03 NEWS

Oncology Nurse Advisor

Stem Cell Transplant Patients Benefit From Inpatient Palliative Care
Oncology Nurse Advisor
CHICAGO — Inpatient palliative care integrated with hematopoietic stem cell transplantation (HSCT) care is associated with improvements in depression and symptoms of post-traumatic stress disorder (PTSD) at 6 months after transplantation

Continue reading

2017-06-03 NEWS

STAT

U.S. could save $825 million a year with a small change in immunotherapy dosing, study says
STAT
That’s the finding of a new study on the immunotherapy drug pembrolizumab, marketed commercially as Keytruda by Merck. By switching to weight-based dosing — instead of a fixed dose of 200 mg — doctors could quickly reduce costs of the intravenous …

Continue reading

2017-06-03 NEWS

Wall Street Pit

CRISPR Found To Have A Dangerous Side-Effect: Unwanted Mutations
Wall Street Pit
People have been calling the CRISPR gene editing technology revolutionary for good reason: there’s no doubt that if used properly, it has the potential to cure many of the world’s worst diseases and medical disorders. And yet the fear that it can be
Unexpected mutations after CRISPR gene-editingBioEdge

all 2 news articles »